Business
Holding(s) in Company
Harwood Capital LLP has increased its holding in MyCelx Technologies Corporation, crossing a notification threshold on December 18, 2025. The firm now holds 1,050,000 voting rights, representing 4.3097% of the total voting rights, up from a previous notification of 3.8377%. This acquisition of voting rights was directly attached to shares, with no financial instruments involved. The ultimate controlling person for Harwood Capital LLP is Christopher Harwood Bernard Mills. Disclaimer*
About this update from Mycelx Technologies Corp.
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN US62847T2024 Issuer Name MYCELX TECHNOLOGIES CORPORATION UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Harwood Capital LLP City of registered office (if applicable) Country of registered office (if applicable) Name City of registered office Country of registered office Harwood Capital LLP London United Kingdom 4. Details of the shareholder Name City of registered office Country of registered office Harwood Capital LLP London United Kingdom 5. Date on which the threshold was crossed or reached 18-Dec-2025 6. Date on which Issuer notified 22-Dec-2025 7. Total positions of person(s) subject to the notification obligation % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer Resulting situation on the date on which threshold was crossed or reached 4.309700 0.000000 4.309700 1050000 Position of previous notification (if applicable) 3.837700 0.000000 3.837700 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1) US62847T2024 1050000 4.309700 Sub Total 8.A 1050000 4.309700% 8B1. Financial Instruments according to (DTR5.3.1R.(1) (a)) Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights Sub Total 8.B1 8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b)) Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights Sub Total 8.B2 9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural pers...
View stock analysis, news, and events for Mycelx Technologies Corp.